Form 4: VolitionRX Director Innes Receives Stock Award in Lieu of Cash Compensation

Director Guy Archibald Innes receives 19,786 restricted stock units (RSUs) from VolitionRX Ltd in lieu of cash compensation.

Summary

• On March 1, 2025, Guy Archibald Innes, a director of VolitionRX Ltd, was granted 19,786 restricted stock units (RSUs) under the company's 2024 Stock Incentive Plan.
• These RSUs were awarded in place of cash compensation.
• The RSUs vest in three installments: 6,596 units on March 1, 2025, 6,595 units on April 1, 2025, and 6,595 units on May 1, 2025.
• Further vesting occurs in a single installment on March 1, 2026, contingent upon continued service.
• Upon vesting and settlement, Innes will receive common stock shares equal to the number of vested RSUs.
• Innes also indirectly owns 1,400,000 shares through The Innes Family Bare Trust 2023, where he serves as Trustee for his children.
• Additionally, he indirectly owns 356,000 shares through The Dill Faulkes Educational Trust Limited, where he is a director and trustee.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, suggesting stability and alignment of interests. The sentiment is neutral to slightly positive.

Positives

• The award of RSUs to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service by the director.

Industry Context

The granting of stock-based compensation to directors is a common practice in the biotechnology industry to align management's interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Stock awards are a typical component of executive compensation packages in the biotech industry.
• Companies like Exact Sciences and Guardant Health also utilize stock options and RSUs to incentivize their leadership teams.
• The specific amount and vesting schedule of the RSUs would need to be compared to peer companies to determine if they are in line with industry standards.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to incentivizing its leadership.

Key Dates